Status:
UNKNOWN
Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma
Lead Sponsor:
Istituto Ortopedico Rizzoli
Collaborating Sponsors:
International Agency for Research on Cancer
Conditions:
Osteosarcoma
Ewing Sarcoma
Eligibility:
All Genders
12+ years
Brief Summary
Osteosarcoma and Ewing sarcoma treatment has not changed in the last 30 years. For other types of cancer the epidemiologic and prognostic correlations between dietary behavior, lifestyle and metaboli...
Detailed Description
MATERIALS \& METHODS A population of 270 patients of \>12 yrs old (pediatric and adults) with new diagnosis of osteosarcoma and Ewing sarcoma will be included. A detailed dietary intake assessment wil...
Eligibility Criteria
Inclusion
- Osteosarcoma and Ewing sarcoma first diagnosis
- No previous chemotherapy treatment
- ≥ 12 years old
- Able to understand the questionnaire
- No malignant tumor diagnosis for the last 5 years
- Control case should have a range of +/- 2 years old for patients \>= 21 years old. For patients between 12 and 21 years old the difference should be +/- 1 years.
Exclusion
- Other tumor type
- Not able to understand the questionnaire
- Patient diagnosed for malignant tumor during the last 5 years
Key Trial Info
Start Date :
March 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
810 Patients enrolled
Trial Details
Trial ID
NCT04735289
Start Date
March 10 2021
End Date
December 31 2024
Last Update
August 4 2023
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Candiolo Cancer Institute
Candiolo, Torino, Italy, 10060
2
Rizzoli Orthopedic Institute - Bologna
Bologna, Italy, 40136
3
Ospedale pediatrico Meyer - U.O. Pediatric Oncoematology
Florence, Italy, 50139
4
IRCCS Istituto Nazionale Tumori - U.O. Pediatric Oncology
Milan, Italy, 20133